TVRD
Nuveen Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-113,930
| Closed | -$104K | – | 3435 |
|
|
2024
Q1 | $104K | Hold |
113,930
| – | – | ﹤0.01% | 3248 |
|
|
2023
Q4 | $84.7K | Buy |
113,930
+1,077
| +1% | +$800 | ﹤0.01% | 3294 |
|
|
2023
Q3 | $190K | Sell |
112,853
-1,531
| -1% | -$2.57K | ﹤0.01% | 3048 |
|
|
2023
Q2 | $324K | Hold |
114,384
| – | – | ﹤0.01% | 2993 |
|
|
2023
Q1 | $562K | Sell |
114,384
-13,235
| -10% | -$65K | ﹤0.01% | 2784 |
|
|
2022
Q4 | $1.37M | Sell |
127,619
-20,426
| -14% | -$219K | ﹤0.01% | 2546 |
|
|
2022
Q3 | $1.39M | Sell |
148,045
-11,218
| -7% | -$105K | ﹤0.01% | 2581 |
|
|
2022
Q2 | $1.45M | Sell |
159,263
-166,488
| -51% | -$1.52M | ﹤0.01% | 2606 |
|
|
2022
Q1 | $3.9M | Sell |
325,751
-2,286
| -0.7% | -$27.4K | ﹤0.01% | 2185 |
|
|
2021
Q4 | $3.86M | Sell |
328,037
-10,498
| -3% | -$124K | ﹤0.01% | 2260 |
|
|
2021
Q3 | $5.16M | Sell |
338,535
-261,118
| -44% | -$3.98M | ﹤0.01% | 2190 |
|
|
2021
Q2 | $8.56M | Sell |
599,653
-15,764
| -3% | -$225K | ﹤0.01% | 1962 |
|
|
2021
Q1 | $13.4M | Buy |
615,417
+240,481
| +64% | +$5.22M | ﹤0.01% | 1614 |
|
|
2020
Q4 | $5.67M | Sell |
374,936
-186,759
| -33% | -$2.83M | ﹤0.01% | 2001 |
|
|
2020
Q3 | $7.15M | Buy |
561,695
+58,972
| +12% | +$750K | ﹤0.01% | 1727 |
|
|
2020
Q2 | $8.6M | Buy |
502,723
+334,015
| +198% | +$5.71M | ﹤0.01% | 1584 |
|
|
2020
Q1 | $2.23M | Sell |
168,708
-297
| -0.2% | -$3.92K | ﹤0.01% | 2137 |
|
|
2019
Q4 | $2.72M | Sell |
169,005
-48,389
| -22% | -$779K | ﹤0.01% | 2299 |
|
|
2019
Q3 | $3.97M | Buy |
217,394
+87,235
| +67% | +$1.59M | ﹤0.01% | 2079 |
|
|
2019
Q2 | $2.8M | Buy |
+130,159
| New | +$2.8M | ﹤0.01% | 2268 |
|